If symptoms persist or worsen, contact your provider right away
Difficult tradeoffs exist for patients and plan sponsors alike. Faust added, We anticipate demand for GLP-1s will only increase in coming years
Step 2: Provider Evaluation A licensed medical provider reviews your submitted information and determines whether GLP-1 medication is appropriate for you
It is not an allergic reaction and not a sign the medication is failing
Before prescribing, clinicians should confirm appropriate indicationseither inadequately controlled type 2 diabetes or obesity with BMI 30 kg/m (or 27 kg/m with weight-related comorbidities such as hypertension or dyslipidemia)
Conclusion: The findings suggest that the GLP-1 receptor agonist liraglutide can reduce methamphetamine-taking behavior under conditions of low intake, whereas in the extended-access protocol, where drug intake escalates, the treatment shows no effect